Covid-19 Vaccine Covaxin: The World Health Organization (WHO) is going to hold a meeting of the Technical Advisory Group on 26 October to consider the emergency use of India’s vaccine vaccine. World Health Organization (WHO) Chief Scientist Soumya Swaminathan gave this information. He said that India is working closely with Biotech to complete the WHO dossier.
Actually, WHO has approved only six Covid-19 vaccines so far. These include Pfizer-BioNtech, Johnson & Johnson, Oxford-AstraZeneca, Moderna, Sinopharm and Sinovac Vaccines. At the same time, now the covaxin is also expected to be approved.
The technical advisory group will meet on Oct 26th to consider EUL (Emergency use listing) for Covaxin. WHO has been working closely with BharatBiotech to complete the dossier: Soumya Swaminathan, Chief Scientist, WHO#COVID19 pic.twitter.com/YKbra0B2qW
— ANI (@ANI) October 17, 2021
At the same time, the Subject Expert Committee of India’s CDSCO i.e. Central Drug Standard Control Organization has recommended Bharat Biotech’s Covaxin to be given to children aged 2 to 18 years. The committee has made its recommendation on the basis of the report of clinical trials conducted on children between 2 to 18 years through the company, in which this vaccine has been found safe and immunogenic for children.
Bharat Biotech’s Corona Vaccine Covaxin is already being given to people above 18 years of age in India. There were no trials in children, so permission was sought for its clinical trials on children in the month of May. After getting permission, this vaccine was tested on children all over the country. In this trial, it was seen whether the vaccine is safe and immunogenic and will it be effective?
The results of clinical trials in children were reported to the Central Drug Standard Control Organization. On which the Subject Expert Committee, which included many experts, is satisfied with the report, the Subject Expert Committee has recommended its approval, on which the final decision is to be taken by DCGI.